Results 121 to 130 of about 92,917 (279)
Beyond bacterial defences: the role of lysozyme in cancer
Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang +4 more
wiley +1 more source
F1000Research, 2016 A multifocal biphasic squamoid alveolar renal cell carcinoma in a 68-year-old man is reported. Four different peripheral tumor nodules were identified on gross examination.
Jose Ignacio Lopez
doaj +1 more source
Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas [PDF]
, 2014 BACKGROUND: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare tumor predisposition syndrome characterized by cutaneous and uterine leiomyomas and papillary type 2 renal cell cancer. Germline mutation of the fumarate hydratase (FH) gene is
Hiroki Kuniyasu +9 more
core +1 more source
Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley +1 more source
Research Progress on Molecular Genetic Alterations of Renal Cell Carcinoma
Zhongliu Fangzhi Yanjiu, 2018 Renal cell carcinoma(RCC) is the most important pathological type of renal carcinoma. Among all the RCC, clear cell renal cell carcinoma(ccRCC) is the most common type, followed by papillary renal cell carcinoma(PRCC) and chromophobe renal cell carcinoma(
WANG Jie, XI Zhijun
doaj +1 more source
Clinical Trials Corner: Optimizing Papillary Renal Cell Carcinoma Care
, 2022 Mamta Parikh
openalex +2 more sources
International Journal of Cancer, Volume 158, Issue 3, Page 763-774, 1 February 2026.What's new? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala +10 more
wiley +1 more source
Different DNA Loidy Patterns for the Differentiation of Common Subtypes of Renal Tumors
Cellular Oncology, 2005 Objectives: The common subtypes of renal tumors are conventional or clear cell carcinoma, papillary carcinoma, chromophobe carcinoma and oncocytoma. Each subtype has its distinct histogenesis and clinical evolution.
Guorong Li +6 more
doaj +1 more source
Outcomes of Genetic Testing in a Genitourinary Genetics Clinic [PDF]
, 2018 Several known hereditary cancer syndromes confer an increased risk for genitourinary (GU)related malignancies. Various guidelines indicate when to refer patients to genetic counseling for GU-related hereditary cancer syndromes but there is limited ...
Pace, Annelise
core +1 more source
Journal of Magnetic Resonance Imaging, Volume 63, Issue 2, Page 525-535, February 2026.ABSTRACT Background Magnetic Resonance Fingerprinting (MRF) is a technique that can provide rapid quantification of multiple tissue properties. Deep learning may potentially contribute to an accelerated acquisition of MRF. Purpose (1) To develop a deep learning method to accelerate the acquisition for kidney MRF; (2) to evaluate its performance in ...
Zhiqing Yin +8 more
wiley +1 more source